Pharmamarketeer

EMA approves expanded indications to Boehringer Ingelheim’s NexGard, NexGard SPECTRA & Broadline

Boehringer Ingelheim, a world leading animal health company, has received additional marketing authorizations from EMA (European Medicines Agency), broadening the preventative impact of its existing

Medhc-fases-banner
Advertentie(s)